Screener
Olema Pharmaceuticals, Inc. OLMA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $3,719 | $9,253 |
| Current portion of operating lease liability | 956 | 1,124 |
| Other current liabilities | 42,492 | 41,425 |
| Total current liabilities | 47,167 | 51,802 |
| Non-current liabilities: | ||
| Operating lease liabilities, net of current portion | — | 69 |
| Long-term borrowing | 3,000 | 3,000 |
| Total liabilities | 50,167 | 54,871 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s total current liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported total current liabilities of $47.17M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s total current liabilities increased by 81.0% year-over-year, from $26.06M to $47.17M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s total current liabilities has grown at a 62.4% compound annual growth rate (CAGR), from $4.59M to $51.8M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Olema Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude